NFDI4DS | UHH-SEMS - Publication Details

Nelson J. Alvis-Zakzuk

ORCID: 0000-0001-9382-214X

Publications

Citations

Views

---

Saved

---

About

Contact & Profiles

A5085934063

Research Areas

Global Public Health Policies and Epidemiology
Healthcare Systems and Reforms
Global Maternal and Child Health
Rheumatoid Arthritis Research and Therapies
Child Nutrition and Water Access
Chronic Disease Management Strategies
Public Health and Environmental Issues
COVID-19 Clinical Research Studies
Health Systems, Economic Evaluations, Quality of Life
Global Health Care Issues
Health and Lifestyle Studies
Autoimmune and Inflammatory Disorders Research
Climate Change and Health Impacts
Biosimilars and Bioanalytical Methods
Respiratory viral infections research
Food Security and Health in Diverse Populations
Public Health and Social Inequalities
Healthcare Policy and Management
Pneumonia and Respiratory Infections
Vaccine Coverage and Hesitancy
Spondyloarthritis Studies and Treatments
Influenza Virus Research Studies
Dermatology and Skin Diseases
Hepatitis C virus research
Air Quality and Health Impacts

Universidade de São Paulo
2022-2025

University of the Coast
2018-2025

World Health Organization Regional Office for the Americas
2025

Instituto de Saúde
2023-2024

Institute for Health Metrics and Evaluation
2020-2024

University of Washington
2020-2024

Weatherford College
2024

World Health Organization
2024

Royal North Shore Hospital
2023

The University of Sydney
2023

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

OPENALEX - Publications

Theo Vos Stephen S Lim Cristiana Abbafati Kaja Abbas Mohammad Abbasi and 95 more

<h2>Summary</h2><h3>Background</h3> In an era of shifting global agendas and expanded emphasis on non-communicable diseases injuries along with communicable diseases, sound evidence trends by cause at the national level is essential. The Global Burden Diseases, Injuries, Risk Factors Study (GBD) provides a systematic scientific assessment published, publicly available, contributed data incidence, prevalence, mortality for mutually exclusive collectively exhaustive list injuries....

10.1016/s0140-6736(20)30925-9 article EN cc-by The Lancet 2020-10-01

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

OPENALEX - Publications

Alize J Ferrari Damian Santomauro Amirali Aali Yohannes Habtegiorgis Abate Cristiana Abbafati and 95 more

Detailed, comprehensive, and timely reporting on population health by underlying causes of disability premature death is crucial to understanding responding complex patterns disease injury burden over time across age groups, sexes, locations. The availability estimates can promote evidence-based interventions that enable public researchers, policy makers, other professionals implement strategies mitigate diseases. It also facilitate more rigorous monitoring progress towards national...

10.1016/s0140-6736(24)00757-8 article EN cc-by The Lancet 2024-04-17

Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

OPENALEX - Publications

Rafael Lozano Nancy Fullman John Everett Mumford Megan Knight Celine M Barthelemy and 95 more

BackgroundAchieving universal health coverage (UHC) involves all people receiving the services they need, of high quality, without experiencing financial hardship. Making progress towards UHC is a policy priority for both countries and global institutions, as highlighted by agenda UN Sustainable Development Goals (SDGs) WHO's Thirteenth General Programme Work (GPW13). Measuring effective at health-system level important understanding whether are aligned with countries' profiles sufficient...

10.1016/s0140-6736(20)30750-9 article EN cc-by The Lancet 2020-08-27

Global Burden of Cardiovascular Diseases and Risks, 1990-2022

OPENALEX - Publications

George A. Mensah Valentı́n Fuster Christopher J L Murray Gregory A. Roth George A. Mensah and 95 more

10.1016/j.jacc.2023.11.007 article EN publisher-specific-oa Journal of the American College of Cardiology 2023-12-01

Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019

OPENALEX - Publications

Katherine Paulson Aruna M Kamath Shazia Alam Kelly Bienhoff Gdiom Gebreheat and 95 more

BackgroundSustainable Development Goal 3.2 has targeted elimination of preventable child mortality, reduction neonatal death to less than 12 per 1000 livebirths, and children younger 5 years 25 for each country by 2030. To understand current rates, recent trends, potential trajectories mortality the next decade, we present Global Burden Diseases, Injuries, Risk Factors Study (GBD) 2019 findings all-cause cause-specific in age, with multiple scenarios 2030 that include consideration effects...

10.1016/s0140-6736(21)01207-1 article EN cc-by The Lancet 2021-08-17

Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021

OPENALEX - Publications

Rachel Black Marita Cross Teklehaimanot Gereziher Haile Garland T Culbreth Jaimie D Steinmetz and 95 more

10.1016/s2665-9913(23)00211-4 article EN The Lancet Rheumatology 2023-09-25

Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026

OPENALEX - Publications

Angela E Micah Kayleigh Bhangdia Ian Cogswell Dylan Lasher Brendan Lidral-Porter and 95 more

<h2>Summary</h2><h3>Background</h3> The COVID-19 pandemic highlighted gaps in health surveillance systems, disease prevention, and treatment globally. Among the many factors that might have led to these is issue of financing national especially low-income middle-income countries (LMICs), as well a robust global system for preparedness. We aimed provide comparative assessment spending at onset pandemic; characterise amount development assistance preparedness response disbursed first 2 years...

10.1016/s2214-109x(23)00007-4 article EN cc-by The Lancet Global Health 2023-01-25

Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019

OPENALEX - Publications

Hmwe Hmwe Kyu Avina Vongpradith Sarah Brooke Sirota Amanda Novotney Christopher Troeger and 95 more

The global burden of lower respiratory infections (LRIs) and corresponding risk factors in children older than 5 years adults has not been studied as comprehensively it younger years. We assessed the trends LRIs across all age groups by sex, for 204 countries territories.

10.1016/s1473-3099(22)00510-2 article EN cc-by The Lancet Infectious Diseases 2022-08-11

Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000–17

OPENALEX - Publications

Aniruddha Deshpande Molly K. Miller-Petrie Paulina A Lindstedt Mathew M Baumann Kimberly B. Johnson and 95 more

<h2>Summary</h2><h3>Background</h3> Universal access to safe drinking water and sanitation facilities is an essential human right, recognised in the Sustainable Development Goals as crucial for preventing disease improving wellbeing. Comprehensive, high-resolution estimates are important inform progress towards achieving this goal. We aimed produce geospatial of facilities. <h3>Methods</h3> used a Bayesian geostatistical model data from 600 sources across more than 88 low-income...

10.1016/s2214-109x(20)30278-3 article EN cc-by The Lancet Global Health 2020-08-19

Burden of diabetes and hyperglycaemia in adults in the Americas, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

OPENALEX - Publications

Ewerton Cousin María Inês Schmidt Kanyin Liane Ong Rafael Lozano Ashkan Afshin and 65 more

High prevalence of diabetes has been reported in the Americas, but no comprehensive analysis burden and related factors for region is available. We aimed to describe type 1 2 that hyperglycaemia Americas from 1990 2019.We used estimates GBD 2019 evaluate adults aged 20 years or older high fasting plasma glucose 25 39 countries territories six regions 2019. The main source estimate mortality attributable chronic kidney disease due was vital registration. Mortality overall (ie, disease)...

10.1016/s2213-8587(22)00186-3 article EN cc-by The Lancet Diabetes & Endocrinology 2022-07-15

Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019

OPENALEX - Publications

Dongze Wu Yingzhao Jin Yuhan Xing Melsew Dagne Abate Mohammadreza Abbasian and 95 more

The causes for immune-mediated inflammatory diseases (IMIDs) are diverse and the incidence trends of IMIDs from specific rarely studied. study aims to investigate pattern trend 1990 2019.We collected detailed information on six major IMIDs, including asthma, bowel disease, multiple sclerosis, rheumatoid arthritis, psoriasis, atopic dermatitis, between 2019, derived Global Burden Disease in 2019. average annual percent change (AAPC) number incidents age standardized rate (ASR) by sex, age,...

10.1016/j.eclinm.2023.102193 article EN cc-by EClinicalMedicine 2023-09-09

Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021

OPENALEX - Publications

Jorge R Ledesma Jianing Ma Meixin Zhang Ann V L Basting Huong T. Chu and 95 more

<h2>Summary</h2><h3>Background</h3> Global evaluations of the progress towards WHO End TB Strategy 2020 interim milestones on mortality (35% reduction) and incidence (20% have not been age specific. We aimed to assess global, regional, national-level burdens trends in tuberculosis its risk factors across five separate groups, from 1990 2021, report age-specific between 2015 2020. <h3>Methods</h3> used Burden Diseases, Injuries, Risk Factors Study 2021 (GBD 2021) analytical framework compute...

10.1016/s1473-3099(24)00007-0 article EN cc-by The Lancet Infectious Diseases 2024-03-19

Global, regional, and national burden of household air pollution, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

OPENALEX - Publications

Fiona B Bennitt Sarah Wozniak Kate Causey Sandra Spearman Chukwuma Okereke and 95 more

10.1016/s0140-6736(24)02840-x article EN cc-by The Lancet 2025-03-01

Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000–17: analysis for the Global Burden of Disease Study 2017

OPENALEX - Publications

Robert C. Reiner Kirsten E. Wiens Aniruddha Deshpande Mathew M Baumann Paulina A Lindstedt and 95 more

Across low-income and middle-income countries (LMICs), one in ten deaths children younger than 5 years is attributable to diarrhoea. The substantial between-country variation both diarrhoea incidence mortality interventions that protect children, prevent infection, treat disease. Identifying subnational regions with the highest burden mapping associated risk factors can aid reducing preventable childhood

10.1016/s0140-6736(20)30114-8 article EN cc-by The Lancet 2020-05-06

Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017

OPENALEX - Publications

Damaris K. Kinyoki Jennifer M. Ross Alice Lazzar-Atwood Sandra B. Munro Lauren E Schaeffer and 95 more

Abstract A double burden of malnutrition occurs when individuals, household members or communities experience both undernutrition and overweight. Here, we show geospatial estimates overweight wasting prevalence among children under 5 years age in 105 low- middle-income countries (LMICs) from 2000 to 2017 aggregate these policy-relevant administrative units. Wasting decreased overall across LMICs between 2017, 8.4% (62.3 (55.1–70.8) million) 6.4% (58.3 (47.6–70.7) million), but is predicted...

10.1038/s41591-020-0807-6 article EN cc-by Nature Medicine 2020-04-20

Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019

OPENALEX - Publications

Amy E. Peden Patricia Cullen Kate Francis Holger Moeller Margaret Peden and 95 more

Globally, transport and unintentional injuries persist as leading preventable causes of mortality morbidity for adolescents. We sought to report comprehensive trends in injury-related adolescents aged 10-24 years during the past three decades.Using Global Burden Disease, Injuries, Risk Factors 2019 Study, we analysed disability-adjusted life-years (DALYs) attributed 204 countries. is reported absolute numbers age-standardised rates per 100 000 population by sex, age group (10-14, 15-19,...

10.1016/s2468-2667(22)00134-7 article EN cc-by The Lancet Public Health 2022-06-30

Global pattern, trend, and cross-country inequality of early musculoskeletal disorders from 1990 to 2019, with projection from 2020 to 2050

OPENALEX - Publications

Yingzhao Jin Cui Guo Mohammadreza Abbasian Mitra Abbasifard J. Haxby Abbott and 95 more

<h2>Summary</h2><h3>Background</h3> This study aims to estimate the burden, trends, forecasts, and disparities of early musculoskeletal (MSK) disorders among individuals ages 15 39 years. <h3>Methods</h3> The global prevalence, years lived with disabilities (YLDs), disability-adjusted life (DALYs), projection, inequality were estimated for MSK diseases, including rheumatoid arthritis (RA), osteoarthritis (OA), low back pain (LBP), neck (NP), gout, other diseases (OMSKDs). <h3>Findings</h3>...

10.1016/j.medj.2024.04.009 article EN cc-by Med 2024-06-03

Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021

OPENALEX - Publications

Michael B. Arndt Yohannes Habtegiorgis Abate Mohsen Abbasi‐Kangevari Samar Abd ElHafeez Michael Abdelmasseh and 95 more

The six global nutrition targets (GNTs) related to low birthweight, exclusive breastfeeding, child growth (ie, wasting, stunting, and overweight), anaemia among females of reproductive age were chosen by the World Health Assembly in 2012 as key indicators maternal health, but there has yet be a comprehensive report on progress for period 2021. We aimed evaluate levels, trends, observed-to-expected prevalence attributable burden from 2021, with projections 2050, 204 countries territories.

10.1016/s0140-6736(24)01821-x article EN cc-by The Lancet 2024-12-01

Mapping development and health effects of cooking with solid fuels in low-income and middle-income countries, 2000–18: a geospatial modelling study

OPENALEX - Publications

Joseph Frostad QuynhAnh P Nguyen Mathew M Baumann Brigette F. Blacker Laurie B. Marczak and 95 more

10.1016/s2214-109x(22)00332-1 article EN cc-by The Lancet Global Health 2022-09-13

Is Colombia an example of successful containment of the 2020 COVID-19 pandemic? A critical analysis of the epidemiological data, March to July 2020

OPENALEX - Publications

Fernando de la Hoz Nelson J. Alvis-Zakzuk Alejandro De la Hoz Alejandro De la Hoz Luz Gómez Del Corral and 1 more

BackgroundColombia detected its first coronavirus disease 2019 (COVID-19) case on March 2, 2020. From 22 to April 25, it implemented a national lockdown that, apparently, allowed the country keep low incidence and mortality rate up mid-May. Forced by economic losses, government then opened many commercial activities, which was followed an increase in cases deaths. This paper presents critical analysis of Colombian surveillance data order identify strengths pitfalls control measures.MethodsA...

10.1016/j.ijid.2020.08.017 article EN cc-by-nc-nd International Journal of Infectious Diseases 2020-08-11

Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021

OPENALEX - Publications

Hmwe Hmwe Kyu Avina Vongpradith Regina-Mae Villanueva Dominguez Jianing Ma Samuel B Albertson and 95 more

10.1016/s1473-3099(24)00691-1 article EN cc-by The Lancet Infectious Diseases 2024-12-01

Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17

OPENALEX - Publications

Kirsten E. Wiens Paulina A Lindstedt Brigette F. Blacker Kimberly B. Johnson Mathew M Baumann and 95 more

BackgroundOral rehydration solution (ORS) is a form of oral therapy (ORT) for diarrhoea that has the potential to drastically reduce child mortality; yet, according UNICEF estimates, less than half children younger 5 years with in low-income and middle-income countries (LMICs) received ORS 2016. A variety recommended home fluids (RHF) exist as alternative forms ORT; however, it unclear whether RHF prevent mortality. Previous studies have shown considerable variation between use, but...

10.1016/s2214-109x(20)30230-8 article EN cc-by The Lancet Global Health 2020-07-22

Tuberculosis patients face high treatment support costs in Colombia, 2021

OPENALEX - Publications

Óscar Andrés Cruz Martínez Ingrid García Gloria Puerto Nelson J. Alvis-Zakzuk Martha Patricia López and 9 more

To estimate the baseline to measure one of three indicators World Health Organization (WHO) End TB strategy (2015-2035), costs incurred by patients affected tuberculosis (TB) during a treatment episode and proportion households facing catastrophic (CC) associated risk factors, in Colombia, 2021.

10.1371/journal.pone.0296250 article EN cc-by PLoS ONE 2024-04-18

Effectiveness of CoronaVac and BNT162b2 COVID-19 mass vaccination in Colombia: A population-based cohort study

OPENALEX - Publications

Ángel Paternina‐Caicedo Mark Jit Nelson Alvis‐Guzmán Juan Carlos Fernández José Carlos Ortiz Hernández and 6 more

In February 2021, Colombia began mass vaccination against COVID-19 using mainly BNT162b2 and CoronaVac vaccines. We aimed to estimate vaccine effectiveness (VE) prevent symptomatic cases, hospitalization, critical care admission, deaths in a cohort of 796,072 insured subjects older than 40 years northern Colombia, setting with high SARS-CoV-2 transmission. identified individuals vaccinated between March 1st 2021 August 15th 2021. included hospitalizations, admissions, patients confirmed as...

10.1016/j.lana.2022.100296 article EN cc-by The Lancet Regional Health - Americas 2022-07-01

Coming Soon ...